⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman
prnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Get Answers in Latest SueWallSt Podcast
accessnewswire.com
MLTX
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Class Action Reminder from Pomerantz LLP for Shareholders of MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Lost Money on MoonLake Immunotherapeutics(MLTX)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
globenewswire.com
MLTX
INVESTOR ALERT: The MoonLake Immunotherapeutics Securities Fraud Class Action is Pending, Investors Urged to Contact BFA Law by December 15 Deadline
newsfilecorp.com
MLTX
MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority
globenewswire.com
MLTX
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
globenewswire.com
MLTX
BAX
JHX
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
globenewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm
globenewswire.com
MLTX